Physiotherapy in Patients Hospitalized Due to Pneumonia.
Effects of a Physiotherapy Program in Patients Hospitalized Due to Pneumonia
1 other identifier
interventional
60
1 country
1
Brief Summary
Acute respiratory infections are the fourth cause of hospitalization in elderly. Various studies have examined the impact of hospitalization in patients with respiratory pathology, showing the need of interventions in order to reduce the impact of hospitalization. The objective of this study is to examine whether a physical therapy intervention can reduce impairment in patients hospitalized due to pneumonia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2015
CompletedFirst Posted
Study publicly available on registry
August 4, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedJuly 12, 2018
July 1, 2018
2.6 years
August 2, 2015
July 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Muscle strength
Quadriceps strength will be assessed with a portable dynamometer. The test will be performed as previously reported.
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Exercise capacity
Five times sit to stand test (5STS) will be used to assess exercise capacity, 5STS is a simple assessment tool that is feasible in all healthcare settings, and may be a rapid method of assessing changes in exercise capacity in COPD and screening for poor physical functioning individuals.
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Secondary Outcomes (6)
Respiratory function
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Dyspnea perception
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Quality of life
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
Functionality
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
Fatigue
Participants will be followed for the duration of hospital stay, an expected average of 8 days.
- +1 more secondary outcomes
Other Outcomes (3)
Dependency levels
Baseline
Comorbidities
Baseline
Nutritional status
Baseline
Study Arms (2)
Experimental group
EXPERIMENTALPatients with a clinical diagnosis of pneumonia will be included in this group. They will be included in a physiotherapy program added to the standard medical treatment.
Control group
OTHERPatients with a clinical diagnosis of pneumonia will be included in this group. They will receive only the standard medical treatment based on cephalosporin with or without erythromycin.
Interventions
Second- or third-generation cephalosporin (cefuroxime, cefotaxime, or ceftriaxone) with or without erythromycin, given parenterally; parenteral therapy should continue until the patient has been afebrile for more than 24 hours and oxygen saturation exceeds 95 percent.
The physiotherapy treatment will be performed during the hospitalization, every day during 45-60 minutes added to the standard medical treatment. I will include breathing exercises, electrostimulation in quadriceps with voluntary contraction and exercises with theraband.
Eligibility Criteria
You may qualify if:
- Diagnosis of pneumonia.
- No contraindication of physiotherapy.
- Signed written consent.
You may not qualify if:
- Contraindications of physiotherapy.
- Neurological, orthopedic or heart disease.
- Prosthetic devices in lower limbs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Health Sciences. University of Granada.
Granada, 18071, Spain
Related Publications (1)
Lopez-Lopez L, Torres-Sanchez I, Rodriguez-Torres J, Cabrera-Martos I, Ortiz-Rubio A, Valenza MC. Does adding an integrated physical therapy and neuromuscular electrical stimulation therapy to standard rehabilitation improve functional outcome in elderly patients with pneumonia? A randomised controlled trial. Clin Rehabil. 2019 Nov;33(11):1757-1766. doi: 10.1177/0269215519859930. Epub 2019 Jun 27.
PMID: 31244327DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Carmen Valenza, PhD
Universidad de Granada
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 2, 2015
First Posted
August 4, 2015
Study Start
September 1, 2015
Primary Completion
April 1, 2018
Study Completion
July 1, 2018
Last Updated
July 12, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share